In this study, combining the bioinformatics of gene expression profiling of bladder cancer cells with or without ALPK2 knockdown and its known role in bladder cancer, DEPDC1A was identified as a potential target of the ALPK2 induced regulation of bladder cancer. The gene discussed is DEPDC1; the disease is urinary bladder carcinoma.